Post-translational modifiers of liver kinase B1/serine/threonine kinase 11 in hepatocellular carcinoma

References

• Hemminki A, Markie D, Tomlinson I, et al. A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature. 1998;391(6663):184–187. doi:10.1038/344329428765
   PubMed Web of Science ®Google Scholar
• Jenne DE, Reimann H, Nezu J, et al. Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet. 1998;18(1):38–43. doi:10.1038/ng0198-389425897
   PubMed Web of Science ®Google Scholar
• Nezu J, Oku A, Shimane M. Loss of cytoplasmic retention ability of mutant LKB1 found in Peutz-Jeghers syndrome patients. Biochem Biophys Res Commun. 1999;261(3):750–755. doi:10.1006/bbrc.1999.104710441497
   PubMed Web of Science ®Google Scholar
• Baas AF, Boudeau J, Sapkota GP, et al. Activation of the tumour suppressor kinase LKB1 by the STE20-like pseudokinase STRAD. Embo J. 2003;22(12):3062–3072. doi:10.1093/emboj/cdg29212805220
   PubMed Web of Science ®Google Scholar
• Boudeau J, Baas AF, Deak M, et al. MO25alpha/beta interact with STRADalpha/beta enhancing their ability to bind, activate and localize LKB1 in the cytoplasm. Embo J. 2003;22(19):5102–5114. doi:10.1093/emboj/cdg49014517248
   PubMed Web of Science ®Google Scholar
• Brajenovic M, Joberty G, Kuster B, Bouwmeester T, Drewes G. Comprehensive proteomic analysis of human Par protein complexes reveals an interconnected protein network. J Biol Chem. 2004;279(13):12804–12811. doi:10.1074/jbc.M31217120014676191
   PubMed Web of Science ®Google Scholar
• Zeqiraj E, Filippi BM, Deak M, Alessi DR, van Aalten DM. Structure of the LKB1-STRAD-MO25 complex reveals an allosteric mechanism of kinase activation. Science. 2009;326(5960):1707–1711. doi:10.1126/science.117837719892943
   PubMed Web of Science ®Google Scholar
• Dorfman J, Macara IG. STRADalpha regulates LKB1 localization by blocking access to importin-alpha, and by association with Crm1 and exportin-7. Mol Biol Cell. 2008;19(4):1614–1626. doi:10.1091/mbc.e07-05-045418256292
   PubMed Web of Science ®Google Scholar
• Alessi DR, Sakamoto K, Bayascas JR. LKB1-dependent signaling pathways. Annu Rev Biochem. 2006;75:137–163. doi:10.1146/annurev.biochem.75.103004.14270216756488
   PubMed Web of Science ®Google Scholar
• Hardie DG, Ross FA, Hawley SA. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol. 2012;13(4):251–262. doi:10.1038/nrm331122436748
   PubMed Web of Science ®Google Scholar
• Sanchez-Cespedes M, Parrella P, Esteller M, et al. Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung. Cancer Res. 2002;62(13):3659–3662.12097271
   PubMed Web of Science ®Google Scholar
• McCabe MT, Powell DR, Zhou W, Vertino PM. Homozygous deletion of the STK11/LKB1 locus and the generation of novel fusion transcripts in cervical cancer cells. Cancer Genet Cytogenet. 2010;197(2):130–141. doi:10.1016/j.cancergencyto.2009.11.01720193846
   PubMedGoogle Scholar
• Pearson HB, McCarthy A, Collins CM, Ashworth A, Clarke AR. Lkb1 deficiency causes prostate neoplasia in the mouse. Cancer Res. 2008;68(7):2223–2232. doi:10.1158/0008-5472.CAN-07-516918381428
   PubMed Web of Science ®Google Scholar
• Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet. 2012;379(9822):1245–1255. doi:10.1016/S0140-6736(11)61347-022353262
   PubMed Web of Science ®Google Scholar
• Gerbes A, Zoulim F, Tilg H, et al. Gut roundtable meeting paper: selected recent advances in hepatocellular carcinoma. Gut. 2017;67(2)380-388. doi:10.1136/gutjnl-2017-315068
   Web of Science ®Google Scholar
• Lepage C, Bossard N, Dejardin O, et al. Trends in net survival from rectal cancer in six European Latin countries: results from the SUDCAN population-based study. Eur J Cancer Prev. 2017;26:S48–S55. doi:10.1097/CEJ.000000000000030528005605
   PubMed Web of Science ®Google Scholar
• Martinez-Lopez N, Garcia-Rodriguez JL, Varela-Rey M, et al. Hepatoma cells from mice deficient in glycine N-methyltransferase have increased RAS signaling and activation of liver kinase B1. Gastroenterology. 2012;143(3):787–798 e781–713. doi:10.1053/j.gastro.2012.05.050
   Web of Science ®Google Scholar
• Barbier-Torres L, Delgado TC, Garcia-Rodriguez JL, et al. Stabilization of LKB1 and Akt by neddylation regulates energy metabolism in liver cancer. Oncotarget. 2015;6(4):2509–2523. doi:10.18632/oncotarget.319125650664
   PubMedGoogle Scholar
• Lee SW, Li CF, Jin G, et al. Skp2-dependent ubiquitination and activation of LKB1 is essential for cancer cell survival under energy stress. Mol Cell. 2015;57(6):1022–1033. doi:10.1016/j.molcel.2015.01.01525728766
   PubMed Web of Science ®Google Scholar
• Zubiete-Franco I, Garcia-Rodriguez JL, Lopitz-Otsoa F, et al. SUMOylation regulates LKB1 localization and its oncogenic activity in liver cancer. EBioMedicine. 2018;40:406-421. doi:10.1016/j.ebiom.2018.12.031
   Web of Science ®Google Scholar
• Martinez-Lopez N, Varela-Rey M, Fernandez-Ramos D, et al. Activation of LKB1-Akt pathway independent of phosphoinositide 3-kinase plays a critical role in the proliferation of hepatocellular carcinoma from nonalcoholic steatohepatitis. Hepatology. 2010;52(5):1621–1631. doi:10.1002/hep.2386020815019
   PubMed Web of Science ®Google Scholar
• Nakau M, Miyoshi H, Seldin MF, Imamura M, Oshima M, Taketo MM. Hepatocellular carcinoma caused by loss of heterozygosity in Lkb1 gene knockout mice. Cancer Res. 2002;62(16):4549–4553.12183403
   PubMed Web of Science ®Google Scholar
• Kim CJ, Cho YG, Park JY, et al. Genetic analysis of the LKB1/STK11 gene in hepatocellular carcinomas. Eur J Cancer. 2004;40(1):136–141.14687797
   PubMed Web of Science ®Google Scholar
• Chen H, Zhang T, Sheng Y, et al. Methylation profiling of multiple tumor suppressor genes in hepatocellular carcinoma and the epigenetic mechanism of 3OST2 regulation. J Cancer. 2015;6(8):740–749. doi:10.7150/jca.1169126185536
   PubMed Web of Science ®Google Scholar
• Luo Z, Yu G, Lee HW, et al. The Nedd8-activating enzyme inhibitor MLN4924 induces autophagy and apoptosis to suppress liver cancer cell growth. Cancer Res. 2012;72(13):3360–3371. doi:10.1158/0008-5472.CAN-12-038822562464
   PubMed Web of Science ®Google Scholar
• Soucy TA, Smith PG, Milhollen MA, et al. An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer. Nature. 2009;458(7239):732–736. doi 10.1038/nature0788419360080
   PubMed Web of Science ®Google Scholar
• Seeler JS, Dejean A. SUMO and the robustness of cancer. Nat Rev Cancer. 2017;17(3):184–197. doi:10.1038/nrc.2016.14328134258
   PubMed Web of Science ®Google Scholar
• Tomasi ML, Tomasi I, Ramani K, et al. S-adenosyl methionine regulates ubiquitin-conjugating enzyme 9 protein expression and sumoylation in murine liver and human cancers. Hepatology. 2012;56(3):982–993. doi:10.1002/hep.2570122407595
   PubMed Web of Science ®Google Scholar
• Li J, Xu Y, Long XD, et al. Cbx4 governs HIF-1alpha to potentiate angiogenesis of hepatocellular carcinoma by its SUMO E3 ligase activity. Cancer Cell. 2014;25(1):118–131. doi:10.1016/j.ccr.2013.12.00824434214
   PubMed Web of Science ®Google Scholar
• Ritho J, Arold ST, Yeh ET. A critical SUMO1 modification of LKB1 regulates AMPK activity during energy stress. Cell Rep. 2015;12(5):734–742. doi:10.1016/j.celrep.2015.07.00226212320
   PubMed Web of Science ®Google Scholar
• Lan F, Cacicedo JM, Ruderman N, Ido Y. SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1. Possible role in AMP-activated protein kinase activation. J Biol Chem. 2008;283(41):27628–27635. doi:10.1074/jbc.M80571120018687677
   PubMed Web of Science ®Google Scholar
• Schimmel J, Eifler K, Sigurethsson JO, et al. Uncovering SUMOylation dynamics during cell-cycle progression reveals FoxM1 as a key mitotic SUMO target protein. Mol Cell. 2014;53(6):1053–1066. doi:10.1016/j.molcel.2014.02.00124582501
   PubMed Web of Science ®Google Scholar
• Ullmann R, Chien CD, Avantaggiati ML, Muller S. An acetylation switch regulates SUMO-dependent protein interaction networks. Mol Cell. 2012;46(6):759–770. doi:10.1016/j.molcel.2012.04.00622578841
   PubMed Web of Science ®Google Scholar
• Zubiete-Franco I, Fernandez-Tussy P, Barbier-Torres L, et al. Deregulated neddylation in liver fibrosis. Hepatology. 2017;65(2):694–709. doi:10.1002/hep.2893328035772
   PubMed Web of Science ®Google Scholar
• Delgado TC, Barbier-Torres L, Zubiete-Franco I, et al. Neddylation, a novel paradigm in liver cancer. Transl Gastroenterol Hepatol. 2018;3:37. doi:10.21037/tgh.2018.06.0530050997
   PubMed Web of Science ®Google Scholar
• Zhang W, Sidhu SS. Development of inhibitors in the ubiquitination cascade. FEBS Lett. 2014;588(2):356–367. doi:10.1016/j.febslet.201324239534
   PubMed Web of Science ®Google Scholar
• Zhou Y, Ji C, Cao M, et al. Inhibitors targeting the SUMOylation pathway: a patent review 2012-2015 (Review). Int J Mol Med. 2018;41(1):3–12. doi:10.3892/ijmm.2017.323129115401
   PubMed Web of Science ®Google Scholar